PAG
REGN icon

Private Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154K Sell
600
-200
-25% -$153K ﹤0.01% 2490
2025
Q4 		$208K Sell
800
-900
-53% -$611K ﹤0.01% 2378
2025
Q3 		$164K Buy
1,700
+700
+70% +$396K ﹤0.01% 2364
2025
Q2 		$102K Buy
+1,000
New +$558K ﹤0.01% 2316
2021
Q1 		– Sell
-200
Closed -$23K – 1958
2020
Q4 		$23K Buy
+200
New +$108K ﹤0.01% 1743

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Private Advisor Group's REGN Position: Q1 2026 in Review

Private Advisor Group reduced its Regeneron Pharmaceuticals (REGN) stake by 2.5% in Q1 2026, selling an estimated $347K and leaving 17,315 shares worth $13.4M. The position accounts for 0.06% of the portfolio, ranked #323.

Private Advisor Group first reported a position in REGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $13.7M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Private Advisor Group held 17,315 shares of Regeneron Pharmaceuticals worth $13.4M as of Q1 2026.
  • Private Advisor Group sold 453 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $347K.
  • Regeneron Pharmaceuticals made up 0.06% of Private Advisor Group's portfolio in Q1 2026, its #323 holding.
  • Private Advisor Group first reported a position in Regeneron Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • Private Advisor Group's Regeneron Pharmaceuticals position peaked at $13.7M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.